$BAH

UBS raises Booz Allen Hamilton stock price target on backlog growth

UBS raised its price target for Booz Allen Hamilton (NYSE:BAH) to $86 from $79, citing backlog growth. The stock trades at $82.34 with a $9.76B market cap. National Security revenue grew 6%, but total revenue declined 6.19% YoY. Analysts have mixed outlooks, with TD Cowen upgrading to Buy and BofA lowering its target to $68.

Original reporting
Published Oct 26, 2026, 2:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BAH
Neutral
high confidence
Mentioned
$BAH
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BAHNeutralMed
01

Why it matters

Analyst upgrades and target raises may attract buying interest, while the downgrade could limit upside, leading to a potentially volatile trading day.

02

Market read

Analyst actions provide fresh guidance that can influence BAH's short-term price movement.

03

What to watch

Tax benefits from FDII planning and the impact of the Ultra acquisition on future earnings.

Relevance 7/10Novelty 7/10Timing: today

Background

The article reports recent analyst rating and price target changes for Booz Allen Hamilton after its fiscal Q2 earnings beat and backlog growth.

Company-level read

Ticker impact

$BAHNeutralHigh confidence
Context

UBS raised its price target to $86, TD Cowen upgraded to Buy with a $95 target, and BofA cut its target to $68, all following the latest earnings beat and backlog growth.

Expected impact

potential upside pressure from the target raises and upgrade, tempered by downside from the downgrade

Evidence & confidence

Price target changes and rating upgrades/downgrades are fresh analyst actions that can move the stock in the short term.

Market effects

Backlog growth signals strength in the defense sector, potentially benefiting peers.

U.S. defense contractors may see modest interest as analysts adjust expectations.

Limited to U.S. defense and government contracting markets.

Counterpoint

Despite the earnings beat, the revenue decline and civil business headwinds could justify a more cautious stance.

Key entities

  • UBS

    Raised price target to $86, maintains Neutral rating.

  • TD Cowen

    Upgraded rating to Buy, raised target to $95.

  • BofA Securities

    Lowered price target to $68, maintains Underperform rating.

Related articles

$BAHHigh

Booz Allen Jumped 7% as TD Cowen Upgrades to Buy on Improving Backlog

Booz Allen Hamilton (BAH) shares rose 7% after TD Cowen upgraded the stock to Buy and raised its price target to $95. The company's funded backlog increased 5% to $5.7 billion, while revenue fell 4%. BAH also raised its fiscal 2027 adjusted EPS guidance to $6.50-$6.70. Analysts cited improving backlog as a positive sign despite falling revenue.

$BAHHighAI 8/10

Why Booz Allen Hamilton (BAH) stock is up today

Booz Allen Hamilton (BAH) stock rose 7.8% after reporting Q2 adjusted earnings of $1.76/share, above estimates, and raising full-year guidance. Revenue was $2.78B, slightly below expectations. Management cited profit growth and a large classified award for the results. The company expects fiscal 2027 revenue of $11.3B to $11.6B and adjusted earnings of $6.50 to $6.70/share.